CAMBRIDGE, Mass.--(BUSINESS WIRE)--
Medicine, Inc. (NASDAQ:FMI) today announced that Michael Pellini,
M.D., president and chief executive officer, is scheduled to present at
the Morgan Stanley Global Healthcare Conference on Wednesday, September
10, 2014, at 8:35 a.m. E.T. in New York City.
A live, listen-only webcast of the presentation may be accessed by
visiting the investors section of the company's website at investors.foundationmedicine.com.
A replay of the webcast will be available shortly after the conclusion
of the presentation and will be archived on the company's website for
two weeks following the presentation.
About Foundation Medicine
Foundation Medicine (NASDAQ: FMI) is a molecular information company
dedicated to a transformation in cancer care in which treatment is
informed by a deep understanding of the genomic changes that contribute
to each patient's unique cancer. The company's clinical assays,
FoundationOne for solid tumors and FoundationOne Heme for hematologic
malignancies, sarcomas and pediatric cancers, provide a fully
informative genomic profile to identify the molecular alterations in a
patient's cancer to help physicians in matching them with relevant
targeted therapies and clinical trials. Foundation Medicine's molecular
information platform aims to improve day-to-day care for patients by
serving the needs of clinicians, academic researchers and drug
developers to help advance the science of molecular medicine in cancer.
For more information, please visit www.FoundationMedicine.com
or follow Foundation Medicine on Twitter
Foundation Medicine® and FoundationOne®
are registered trademarks and Interactive Cancer Explorer™ is a
trademark of Foundation Medicine, Inc.
Pure Communications, Inc.
Khaled Habayeb, 617-418-2283
Source: Foundation Medicine, Inc.
News Provided by Acquire Media